Zobrazeno 1 - 10
of 77
pro vyhledávání: '"O. Raguin"'
Autor:
Claire Bernhard, Alexandra Oudot, Bertrand Collin, Pierre-Simon Bellaye, Mathieu Moreau, D. Vandroux, A. Cochet, L. Dumont, Franck Denat, O. Raguin, J.M. Vrigneaud, F. Brunotte
Publikováno v:
Clinical and Translational Oncology
Clinical and Translational Oncology, 2018, 〈10.1007/s12094-018-1886-4〉
Clinical & Translational Oncology
Clinical and Translational Oncology, Springer, 2018, 20 (12), pp.1557-1570. ⟨10.1007/s12094-018-1886-4⟩
Clinical and Translational Oncology, 2018, 〈10.1007/s12094-018-1886-4〉
Clinical & Translational Oncology
Clinical and Translational Oncology, Springer, 2018, 20 (12), pp.1557-1570. ⟨10.1007/s12094-018-1886-4⟩
Purpose This study aimed to investigate theranostic strategies in colorectal and skin cancer based on fragments of cetuximab, an anti-EGFR mAb, labeled with radionuclide with imaging and therapeutic properties, 111In and 177Lu, respectively. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19bb86f3963b2a46376b7bb4bc7d1af5
https://hal.archives-ouvertes.fr/hal-01802320
https://hal.archives-ouvertes.fr/hal-01802320
Autor:
Pierre Fumoleau, P-S Bellaye, Alexandra Oudot, O. Raguin, L. Dumont, A Savina, François Brunotte, J.M. Vrigneaud, Bertrand Collin, F Bouquet, Claire Bernhard
Publikováno v:
Cancer Research
Cancer Research, American Association for Cancer Research, 2018, 78 (4 Supplement), pp.P5-01-03-P5-01-03. ⟨10.1158/1538-7445.SABCS17-P5-01-03⟩
Cancer Research, American Association for Cancer Research, 2018, 78 (4 Supplement), pp.P5-01-03-P5-01-03. ⟨10.1158/1538-7445.SABCS17-P5-01-03⟩
Introduction: HER2 is positive in approximately 20-30% of all breast cancer and is associated with poor prognosis, higher mortality and higher metastatic incidence. Current diagnosis of HER2 expression relies on invasive methods requiring tissue biop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3dc929555c10880f07875edfa1819a8
https://hal.archives-ouvertes.fr/hal-01794241
https://hal.archives-ouvertes.fr/hal-01794241
Autor:
Sophie Poty, H. J. Wester, Franck Denat, Johannes Notni, Jakub Šimeček, Victor Goncalves, O. Raguin, Bertrand Collin, Christine Goze, Mathieu Moreau, Claire Bernhard, Pauline Désogère, François Brunotte, Frédéric Boschetti
Publikováno v:
Nuclear Medicine and Biology. :S11-S12
Autor:
Frédéric Boschetti, Franck Denat, François Brunotte, Jean-Marc Vrigneaud, Paul Walker, O. Raguin, Bertrand Collin, Alexandra Oudot, Claire Bernhard, Sophie Poty, M. Guillemin, Mathieu Moreau, Christine Goze
Publikováno v:
Dalton Transactions
Dalton Transactions, Royal Society of Chemistry, 2017, 〈 https://www.ncbi.nlm.nih.gov/pubmed/28861553〉. 〈10.1039/c7dt01772c〉
Dalton Transactions, Royal Society of Chemistry, 2017, ⟨10.1039/c7dt01772c⟩
Dalton Transactions, Royal Society of Chemistry, 2017, 〈 https://www.ncbi.nlm.nih.gov/pubmed/28861553〉. 〈10.1039/c7dt01772c〉
Dalton Transactions, Royal Society of Chemistry, 2017, ⟨10.1039/c7dt01772c⟩
International audience; Improved bifunctional chelating agents (BFC) are required for copper-64 radiolabelling of monoclonal antibodies (mAbs) under mild conditions to yield stable, target-specific imaging agents. Four different bifunctional chelatin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb89bb3094d2f0ff4fc2670193aedd29
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01620489
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01620489
Autor:
Céline Mirjolet, Philippe Maingon, Cedric Seignez, Nadine Millot, Anne-Laure Papa, O. Raguin, Catherine Paul, Gilles Truc, Gilles Créhange
Publikováno v:
Radiotherapy and Oncology. 108:136-142
Background and purpose One of the new challenges to improve radiotherapy is to increase the ionizing effect by using nanoparticles. The interest of titanate nanotubes (TiONts) associated with radiotherapy was evaluated in two human glioblastoma cell
Autor:
Alain Meulemans, Azzam Saleh-Mghir, Geneviève Martet, Dominique Le Guludec, Françoise Chau, O. Raguin, Jean-Marc Vrigneaud, Rachida Lebtahi, Laure Sarda-Mantel, Mick M. Welling, Florence Hervatin
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 34:1302-1309
(99m)Tc-UBI 29-41 (UBI), an antimicrobial peptide, specifically targets bacteria. We tested the ability of UBI to discriminate between infected and uninfected prosthetic joints using a rabbit model previously validated.Left knee arthroplasty was perf
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Anne Gruaz-Guyon, William Rostène, Jacques Barbet, O. Raguin, Emmanuel Gautherot, Marc Hillairet de Boisferon, Corrine Manetti
Publikováno v:
Letters in Peptide Science. 4:331-339
The advantages of bivalent hapten-bearing peptides for the detection of tumours pretargeted with bispecific antibodies have been demonstrated. This technology is now considered for radioimmunotherapy and bivalent haptens designed to target131I are ne
Autor:
Bernd J. Pichler, Olivier Duchamp, H. J. Machulla, Gerald Reischl, D. Bukala, O. Raguin, Claus D. Claussen, D. Kukuk, Judenhofer, F. Cay, Stefan Wiehr
Publikováno v:
RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 181
Publikováno v:
ResearcherID
Pretargeted delivery of radionuclides is based upon bispecific immunoconjugates that bind a target tumor antigen and a small molecule carrying the active payload. This strategy is supposed to combine the advantage of antibodies to track tumor cells i